Literature DB >> 25506586

Current and Future Role of the Gastroenterologist in GI Cancer Management.

John M Carethers1.   

Abstract

With advances in technology, advances in the understanding of biology of cancer, and the advent of improved and novel therapies, the role of the gastroenterologist has been modified greatly over the past 2 decades, and continues to be shaped by the knowledge, skill, and opportunity to capitalize on the unique position that gastroenterologists hold in the patient care continuum. The gastroenterologist is evolving from a "pure" diagnostician to an endoscopic surgeon, a geneticist, a nutritionist, an immunologist and chemotherapist, and palliative care physician.

Entities:  

Keywords:  chemotherapy; endoscopic surgery; gastroenterologist; genetics; training

Year:  2013        PMID: 25506586      PMCID: PMC4262247     

Source DB:  PubMed          Journal:  J Dig Cancer Rep        ISSN: 2288-1581


  7 in total

1.  American Gastroenterological Association medical position statement: Role of the gastroenterologist in the management of esophageal carcinoma.

Authors:  Kenneth K Wang; Michel Wongkeesong; Navtej S Buttar
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 2.  Oncology training for the gastroenterologist: a test-case for subspecialization in gastroenterology?

Authors:  Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2008-09-04       Impact factor: 22.682

3.  The future role of the gastroenterologist in digestive oncology: an international perspective.

Authors:  Sidney J Winawer; Pankaj Jay Pasricha; Wolff Schmiegel; Frank A Sinicrope; Joseph Sung; Thomas Seufferlein; Abdel Meguid Kassem; Reza Malekzadeh; Robert C Kurtz; Meinhard Classen; Guido N Tytgat
Journal:  Gastroenterology       Date:  2011-08-24       Impact factor: 22.682

4.  Proteomics, genomics, and molecular biology in the personalized treatment of colorectal cancer.

Authors:  John M Carethers
Journal:  J Gastrointest Surg       Date:  2012-07-04       Impact factor: 3.452

5.  Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

Authors:  Xiaoyun Liao; Paul Lochhead; Reiko Nishihara; Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Yu Imamura; Zhi Rong Qian; Yoshifumi Baba; Kaori Shima; Ruifang Sun; Katsuhiko Nosho; Jeffrey A Meyerhardt; Edward Giovannucci; Charles S Fuchs; Andrew T Chan; Shuji Ogino
Journal:  N Engl J Med       Date:  2012-10-25       Impact factor: 91.245

6.  Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.

Authors:  John M Carethers; E Julieta Smith; Cynthia A Behling; Lanchinh Nguyen; Akihiro Tajima; Ryan T Doctolero; Betty L Cabrera; Ajay Goel; Christian A Arnold; Katsumi Miyai; C Richard Boland
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

7.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

  7 in total
  2 in total

1.  Poor Knowledge of Colorectal Cancer Screening and Surveillance Guidelines in a National Cohort of Digestive Disease Specialists.

Authors:  Rushad Patell; Abhishek Karwa; Rocio Lopez; Carol A Burke
Journal:  Dig Dis Sci       Date:  2018-10-28       Impact factor: 3.199

2.  Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.

Authors:  Yasushi Hamaya; Carla Guarinos; Stephanie S Tseng-Rogenski; Moriya Iwaizumi; Ritabrata Das; Rodrigo Jover; Antoni Castells; Xavier Llor; Montserrat Andreu; John M Carethers
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.